Showing results (1411-1420 of 1,729) with videos related to

Sort By:
Pageof 173
The Lancet. Oncology|September 13, 2016
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trialJonathan A Ledermann, Philipp Harter, Charlie Gourley, et al.
Journal of the American Heart Association|August 27, 2013
Hypotension due to Kir6.1 gain-of-function in vascular smooth muscleAnlong Li, Russell H Knutsen, Haixia Zhang, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2024
Epigenetic profiling of prostate cancer reveals potential prognostic signaturesSimon Bernatz, Ian G Reddin, Tim R Fenton, et al.
Gynecologic Oncology Research and Practice|March 14, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trialRadoslav Chekerov, Philipp Harter, Stefan Fuxius, et al.
The American Journal of Pathology|June 14, 2017
Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic GliomasMatija Snuderl, Guoan Zhang, Pamela Wu, et al.
Human Mutation|September 15, 2018
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trialKonstantin Weber-Lassalle, Philipp Harter, Jan Hauke, et al.
Nature Protocols|March 1, 2023
A flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissuesDaniel Spitzer, Maryam I Khel, Tim Pütz, et al.
Neurosurgery|March 26, 2026
The Impact of Programmable Valves on the Risk and Severity of Subdural Collections in Patients With Normal Pressure HydrocephalusSpencer Frome, Jeffrey H Wisoff, Hammad A Khan, et al.
British Journal of Cancer|December 19, 2021
Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)Christina Fotopoulou, Andrea Rockall, Haonan Lu, et al.
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
Pageof 173